Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹1,697 Cr₹1,212 Cr₹849 Cr₹47 Cr₹299 Cr

What is the latest Cash Flow from Operating Activities ratio of NATCO PHARMA ?

The latest Cash Flow from Operating Activities ratio of NATCO PHARMA is ₹1,697 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹1,697 Cr
Mar2024₹1,212 Cr
Mar2023₹849 Cr
Mar2022₹47 Cr
Mar2021₹299 Cr

How is Cash Flow from Operating Activities of NATCO PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹1,697 Cr
40.05
Mar2024 ₹1,212 Cr
42.69
Mar2023 ₹849 Cr
1,726.02
Mar2022 ₹47 Cr
-84.44
Mar2021 ₹299 Cr -

Compare Cash Flow from Operating Activities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹17,700.5 Cr 10.7% 18.3% 21.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

10.7%

18.3%

21.8%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses